Summary
- Wright Medical has agreed to acquire Cartiva for $435 million cash.
- Cartiva has developed a unique great toe injury and osteoarthritis implant treatment.
- WMGI is paying a fair price for Cartiva's growth trajectory and future EBITDA contribution.
- Members of our private investing community, IPO Edge, get our best ideas and insights. Get started today >>
Quick Take
Wright Medical Group (WMGI) has announced it has agreed to acquire Cartivafor $435 million.
Cartiva develops cartilage injury and osteoarthritis treatment products.
WMGI is paying a reasonable price for Cartiva’s fast-growing and easy-to-sell implant product.
